This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Plantago ovata seed is a plant extract indicated in the treatment of occasional constipation.

Generic Name
Plantago ovata seed
DrugBank Accession Number
DB14585
Background

Not Available

Type
Biotech
Groups
Approved, Experimental, Investigational
Synonyms
  • Blond psyllium
  • Blonde psyllium
  • Indian plantain seed
  • Indian psyllium
  • Ispaghul
  • Ispaghula
  • Ispaghula extract
  • Ispaghula husk
  • Ispaghula seed
  • Plantaginis ovatae semen
  • Plantaginis ovatae testa
  • Plantago brunnea seed
  • Plantago fastigiata seed
  • Plantago gooddingii seed
  • Plantago insularis seed
  • Plantago minima seed
  • Psyllium seed, blonde

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Plantago ovata seed.
AclidiniumThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Plantago ovata seed is combined with Alloin.
AmantadineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Plantago ovata seed.
AmiodaroneThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amiodarone.
AmitriptylineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amitriptyline.
AmlodipineThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amlodipine.
AmobarbitalThe therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Amobarbital.
Interactions
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
EVAGEL POWDER FOR ORAL SOLUTION 3.5gPowder, for solutionOralAPEX PHARMACY MARKETING SDN. BHD.2020-09-08Not applicableMalaysia flag
FYBOGEL ORANGEGranule3.5 gOralบริษัท เรกคิทท์ เบนคีเซอร์ (ประเทศไทย) จำกัด1994-12-22Not applicableThailand flag
FYBOGEL ORANGE SACHETPowder, for solutionOralRB (HEALTH) MALAYSIA SDN BHD2020-09-08Not applicableMalaysia flag
MucilinPowder2.45 g/5gOralParadigm Pharmaceuticals Inc2018-07-302019-12-22US flag
MUCILIN ORANGE FLAVOURPowder2.45 gOralบริษัท เบอร์ลินฟาร์มาซูติคอลอินดัสตรี้ จำกัด2020-08-13Not applicableThailand flag
Mucilin SfPowder3.5 g/5gOralParadigm Pharmaceuticals Inc2018-07-302019-12-22US flag
MUCILIN SFPowder3.5 gOralบริษัท เบอร์ลินฟาร์มาซูติคอลอินดัสตรี้ จำกัด2020-08-13Not applicableThailand flag
MUCILIN SFPowder3.5 gOralบริษัท เบอร์ลินฟาร์มาซูติคอลอินดัสตรี้ จำกัด2017-10-11Not applicableThailand flag
MUCILIN SF MIXED BERRY FLAVOURPowder3500 mgOralบริษัท เบอร์ลินฟาร์มาซูติคอลอินดัสตรี้ จำกัด2016-02-04Not applicableThailand flag
MUCILIN SF STRAWBERRY FLAVOURPowder3500 mgOralบริษัท เบอร์ลินฟาร์มาซูติคอลอินดัสตรี้ จำกัด2016-02-17Not applicableThailand flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
อาจิโอแล็กซ์Plantago ovata seed (52 G/100G) + Plantago seed (2.2 G/100G) + Senna leaf (0.3 G/100G)Granuleบริษัท เมด้า ฟาม่าร์ (ประเทศไทย)2016-09-26Not applicableThailand flag

Categories

ATC Codes
A06AC51 — Ispaghula, combinations
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
K9NXW456E2
CAS number
Not Available

References

General References
  1. DailyMed: Mucilin (plantago ovata) oral powder [Link]
RxNav
104129

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2TerminatedTreatmentSyndrome, Metabolic1
Not AvailableUnknown StatusTreatmentFecal Incontinence1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Powder, for solutionOral
GranuleOral79.618 g
PowderOral2.45 g/5g
PowderOral2.45 g
PowderOral3.5 g/5g
PowderOral3500 mg
GranuleOral
PowderOral3.4 g
PowderOral49 g
GranuleOral3.5 g
Granule
PowderOral3.5 g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at August 19, 2018 20:47 / Updated at May 14, 2021 01:06